New series

the long view.

Glaucoma is a long game. Three conversations with four surgeons on the decisions that shape a patient's vision over decades, not visits.

The Long View is an editorial series from iD Social on interventional glaucoma. Each episode is one surgeon, one idea, and the reasoning behind it. Full episodes run under five minutes. New episodes this fall.

The preview

the surgeons.

  • Headshot of Deborah Ristvedt, DONo. 01

    Deborah Ristvedt, DO

    Vance Thompson Vision

  • Headshot of Leonard Seibold, MDNo. 02

    Leonard Seibold, MD

    University of Colorado

  • Headshot of William Wiley, MDNo. 03

    William Wiley, MD

    Cleveland Eye Clinic

  • Headshot of Camila Albo, MDNo. 03

    Camila Albo, MD

    Cleveland Eye Clinic

the episodes.

01Watch

No. 01 / Oct 30

are they really taking them?

Deborah Ristvedt, DO

Vance Thompson Vision

Interventional glaucoma starts with an honest question about drops. Dr. Ristvedt on why waiting is a decision too, and what she wants every cataract surgeon to hear.

watch episode 01
02Coming soon

No. 02 / Coming soon

medication free at two years.

Leonard Seibold, MD

The 24-month interim read from the VENICE trial, and what it means when more than 80% of eyes are off drops.

coming soon
03Coming soon

No. 03 / Coming soon

any MIGS beats none.

William Wiley, MD and Camila Albo, MD

Cleveland Eye Clinic

Where MIGS fits when you are training to be a cataract refractive surgeon, and why you treat it when you are already there.

coming soon

This independent program was supported by New World Medical.

Newsletter

Get iD Social in your inbox.

Get new eyecare shows, KOL interviews, and industry highlights delivered straight to your inbox. No spam — just the content worth watching.